Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women

CONTEXT: Studies suggest that menopausal hormone therapy (MHT) prevents type 2 diabetes (T2D). The combination of conjugated estrogens (CE) with the selective estrogen receptor modulator bazedoxifene (BZA) is an MHT that improves obesity and T2D in preclinical models of menopausal metabolic syndrome...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Lovre, Dragana, Peacock, Erin, Katalenich, Bonnie, Moreau, Cynthia, Xu, Beibei, Tate, Chandra, Utzschneider, Kristina M, Gautier, Jean-François, Fonseca, Vivian, Mauvais-Jarvis, Franck
Format: Artigo
Langue:Inglês
Publié: Endocrine Society 2019
Sujets:
Clinical Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676076/
https://ncbi.nlm.nih.gov/pubmed/31384719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-00074
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires